Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Ceptaris resubmits NDA for proprietary gel formulation of chemotherapeutic agent

March 1, 2013

HanAll BioPharma presents new AMPK activators

March 1, 2013

Team describes methods to derive toolboxes of macrocyclic compounds

March 1, 2013

Boehringer Ingelheim commences pivotal trial of volasertib in acute myeloid leukemia

Feb. 28, 2013

Taiho Pharmaceutical seeks Japanese approval for TAS-102 in recurrent colorectal cancer

Feb. 28, 2013

Sunshine Biopharma gives update on Adva-27a testing

Feb. 28, 2013

Japanese group discloses new ERRalpha inverse agonists

Feb. 27, 2013

Merck KGaA patents new LPA2 receptor antagonists

Feb. 27, 2013

Antisense Pharma revises development strategy for anticancer candidate

Feb. 27, 2013

Regorafenib granted priority review in Japan

Feb. 26, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Taiwan biotech looks outward in next phase of growth
BioWorld
Taiwan’s biotechnology sector was built around domestic health needs, including vaccines and drug manufacturing, but it is increasingly looking outward – to...